Rituximab vs Fingolimod in JCV+ Individuals MStranslate April 5, 2016 Fingolimod, Natalizumab, Research, Rituximab Research Summary: Rituximab versus fingolimod after natalizumab in multiple sclerosis patients The background Whilst natalizumab has emerged as a potent treatment for multiple sclerosis (MS), it is also...
Natalizumab, B cells and Multiple Sclerosis MStranslate March 29, 2016 B Cells, Basic Sciences, Natalizumab, Research, Treatments Research Summary: Cutting Edge: Integrin a4 is required for regulatory B cell control of experimental autoimmune encephalomyelitis The background For a long time, multiple sclerosis was regarded as an...
Progressive Multifocal Leukoencephalopathy (PML) MStranslate September 14, 2015 Dimethyl fumarate, Natalizumab, Research The subject of progressive multifocal leukoencephalopathy (PML) has become very topical for people with multiple sclerosis, though it can still be quite confusing for many people. To help, we have prepared...
Fingolimod After Natalizumab & Short-term Relapse Risk MStranslate March 27, 2014 Fingolimod, Natalizumab, Research, Treatments Dr Vilija Jokubaitis et al Natalizumab (Tysabri) is an antibody used for the treatment of multiple sclerosis (MS). It is currently the strongest drug available for the treatment of MS, however, it has also...
